NCT00565253View on ClinicalTrials.gov

Inhaled Nitric Oxide in Pulmonary Embolism

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

December 31, 2009

Conditions
Pulmonary Embolism
Interventions
DRUG

Inhaled nitric oxide (NO)

20 ppm for 15 minutes

Trial Locations (1)

1090

University of Emergency Medicine, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00565253 - Inhaled Nitric Oxide in Pulmonary Embolism | Biotech Hunter | Biotech Hunter